NCT00157118View on ClinicalTrials.gov

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2003

Primary Completion Date

March 17, 2005

Study Completion Date

March 17, 2005

Conditions

Protein C Deficiency

Interventions

DRUG

Protein C Concentrate (Human) Vapor Heated

Trial Locations (12)

Unknown

Los Angeles

Denver

Atlanta

Indianapolis

Lexington

Boston

Cincinnati

Cleveland

Dayton

Fort Worth

Galveston

Houston

All Listed Sponsors

lead

Baxalta now part of Shire

INDUSTRY

NCT00157118 - Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency | Biotech Hunter | Biotech Hunter